Rx Cannabis : Will Dr Reddy's recent acquisition of Nimbus help mainstream the therapeutic plant?

  • HOME
  • /
  • News
  • /
  • Rx Cannabis : Will Dr Reddy's recent acquisition of Nimbus help mainstream the therapeutic plant?

Rx Cannabis : Will Dr Reddy's recent acquisition of Nimbus help mainstream the therapeutic plant?
10-Feb-22 05:00:27

KIRAN KABTTA SOMVANSHI | 28:42 MIN | FEBRUARY 10, 2022, 8:00 AM IST

The psychotropic qualities of Cannabis have always been admired, used and also abused both around the world and in India. Medical cannabis however has evolved into a multi-billion dollar space with Big Pharma. Will Dr Reddy's recent acquisition of German medical cannabis firm Nimbus help mainstream the therapeutic plant? Kiran Somvanshi delves deeper into conversation with Erez Israeli, CEO of DR. Reddy's Laboratories, Anay Shukla, Founding Partner of Arogya Legal, a healthcare law firm and Avnish Pandya, Co-founder of the Bombay Hemp Co. Credits - CNBC, fool.com, Cannabis Broadcast Station, bloomberg.

Source:- Economic Times